P. Collins

4.0k total citations · 1 hit paper
111 papers, 3.2k citations indexed

About

P. Collins is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, P. Collins has authored 111 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Surgery and 27 papers in Epidemiology. Recurrent topics in P. Collins's work include Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Lipoproteins and Cardiovascular Health (18 papers) and Cholesterol and Lipid Metabolism (16 papers). P. Collins is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Lipoproteins and Cardiovascular Health (18 papers) and Cholesterol and Lipid Metabolism (16 papers). P. Collins collaborates with scholars based in Ireland, United States and United Kingdom. P. Collins's co-authors include Jogin H. Thakore, Martina Ryan, D. Owens, G. H. Tomkin, Alan Johnson, F G Winder, Neda Sharifi, Sterling Chaykin, P.R.J. Matthews and Constantin Genigeorgis and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

P. Collins

109 papers receiving 3.0k citations

Hit Papers

Impaired Fasting Glucose Tolerance in First-Episode, Drug... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Collins Ireland 27 908 669 606 585 555 111 3.2k
Margit Hamosh United States 48 981 1.1× 1.1k 1.7× 284 0.5× 1.2k 2.0× 1.2k 2.1× 182 6.7k
Sandeep Gupta United States 31 383 0.4× 761 1.1× 378 0.6× 512 0.9× 567 1.0× 98 3.4k
Paul Hamosh United States 38 644 0.7× 687 1.0× 174 0.3× 563 1.0× 728 1.3× 144 4.4k
Michael H. Court United States 49 417 0.5× 1.8k 2.6× 338 0.6× 398 0.7× 332 0.6× 190 7.6k
D. B. A. Silk United Kingdom 42 241 0.3× 924 1.4× 561 0.9× 690 1.2× 1.8k 3.3× 179 5.8k
Ming Li China 33 491 0.5× 1.4k 2.0× 114 0.2× 599 1.0× 706 1.3× 204 3.8k
Susan S. Baker United States 39 768 0.8× 2.5k 3.8× 314 0.5× 2.6k 4.4× 1.4k 2.5× 121 6.6k
Mercedes Gil‐Campos Spain 31 311 0.3× 1.1k 1.6× 199 0.3× 712 1.2× 1.0k 1.9× 145 3.9k
Robert F. Grimble United Kingdom 38 394 0.4× 829 1.2× 154 0.3× 556 1.0× 1.2k 2.1× 97 4.9k
Kelly A. Tappenden United States 40 357 0.4× 860 1.3× 265 0.4× 255 0.4× 1.8k 3.3× 95 4.5k

Countries citing papers authored by P. Collins

Since Specialization
Citations

This map shows the geographic impact of P. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Collins more than expected).

Fields of papers citing papers by P. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Collins. The network helps show where P. Collins may publish in the future.

Co-authorship network of co-authors of P. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of P. Collins. A scholar is included among the top collaborators of P. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Collins. P. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koozehchian, M, Conrad P. Earnest, Y Jung, et al.. (2017). Dose Response to One Week of Supplementation of a Multi-Ingredient Preworkout Supplement Containing Caffeine Before Exercise. 7(3). 81–94. 9 indexed citations
2.
WINDER, FRANK G. & P. Collins. (2015). The Effect of Isoniazid on Nicotinamide Nucleotide Concentrations in Tubercle Bacilli. American Review of Respiratory Disease.
3.
McGarrigle, Sarah A., Sarah O’Neill, Niamh Moran, et al.. (2010). IntegrinαIIbβ3exists in an activated state in subjects with elevated plasma homocysteine levels. Platelets. 22(1). 63–71. 9 indexed citations
4.
O’Neill, H.A., Janne Lebeck, P. Collins, et al.. (2007). Aldosterone-mediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitus. Nephrology Dialysis Transplantation. 23(5). 1546–1555. 14 indexed citations
5.
Phillips, Catherine M., D. Owens, P. Collins, & G. H. Tomkin. (2005). Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes. Atherosclerosis. 181(1). 109–114. 24 indexed citations
6.
Ryan, Martina, P. Collins, & Jogin H. Thakore. (2003). Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia. American Journal of Psychiatry. 160(2). 284–289. 666 indexed citations breakdown →
7.
Phillips, Catherine M., Claire Madigan, D. Owens, P. Collins, & G. H. Tomkin. (2002). Defective Chylomicron Synthesis as a Cause of Delayed Particle Clearance in Diabetes?. Journal of Diabetes Research. 3(3). 171–178. 12 indexed citations
8.
Phillips, Jack, et al.. (2001). Genetic Evaluation of Lipoprotein(a) in Intracranial Aneurysm Disease. Neurosurgery. 49(1). 133–142. 8 indexed citations
11.
Dimitriadis, Evdokia, Michael Griffin, D. Owens, et al.. (1995). Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia. 38(11). 1300–1306. 51 indexed citations
12.
Dimitriadis, Evdokia, Michael Griffin, D. Owens, et al.. (1995). Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia. 38(11). 1300–1306. 3 indexed citations
13.
Deegan, Patrick, et al.. (1995). Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia. Acta Diabetologica. 32(4). 244–250. 7 indexed citations
14.
Deegan, Patrick, et al.. (1994). Alterations in apolipoprotein B-48 in the postprandial state in NIDDM. Diabetologia. 37(12). 1259–1264. 30 indexed citations
15.
Stinson, J., et al.. (1993). Hyperinsulinaemia is Associated with Stimulation of Cholesterol Synthesis in Both Type 1 and Type 2 Diabetes. Diabetic Medicine. 10(5). 412–419. 8 indexed citations
16.
Owens, D., P. Collins, Alan Johnson, et al.. (1991). Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1082(3). 303–309. 19 indexed citations
17.
Collins, P., A. McDiarmid, L.H. Thomas, & P.R.J. Matthews. (1985). Comparison of the pathogenicity of Mycobacterium paratuberculosis and Mycobacterium SPP isolated from the wood pigeon (Columba palumbus-L). Journal of Comparative Pathology. 95(4). 591–597. 13 indexed citations
18.
Moriarty, M., Gillian O’Loughlin, Alan Johnson, et al.. (1983). A comparative study of a number of nutritional and immunological indices in patients with skin carcinoma. Irish Journal of Medical Science (1971 -). 152(6). 242–245. 1 indexed citations
19.
Johnson, Alan H. & P. Collins. (1979). The Effects of Sera from Cancer Patients on Phytohaemagglutinin-Induced Lymphocyte Transformation. Biochemical Society Transactions. 7(3). 525–527. 1 indexed citations
20.
Matthews, P.R.J. & P. Collins. (1978). Standardisation Of Inocula for Assessing the Virulence of Strains ofAvium-Intracellulare Mycobacteria in Chickens. Journal of Medical Microbiology. 11(1). 47–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026